These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8074 related articles for article (PubMed ID: 2254373)

  • 21. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
    Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
    Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM; Gulati SC
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of sparsomycin analogs as potential antitumor agents.
    Dubois RJ; Lin CC; Michel BL
    J Pharm Sci; 1975 May; 64(5):825-9. PubMed ID: 1151655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065.
    Li LH; Kelly RC; Warpehoski MA; McGovren JP; Gebhard I; DeKoning TF
    Invest New Drugs; 1991 May; 9(2):137-48. PubMed ID: 1874598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells.
    Ching LM; Finlay GJ; Joseph WR; Baguley BC
    Eur J Cancer; 1990 Jan; 26(1):49-54. PubMed ID: 2138478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
    Nishikawa K; Shibasaki C; Hiratsuka M; Arakawa M; Takahashi K; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1101-9. PubMed ID: 1955393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
    Schurig JE; Bradner WT; Basler GA; Rose WC
    Invest New Drugs; 1989 Jul; 7(2-3):173-8. PubMed ID: 2793369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors.
    Aamdal S; Fodstad O; Kaalhus O; Pihl A
    Int J Cancer; 1986 Apr; 37(4):579-87. PubMed ID: 3957463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XB596, a promising bis-naphthalimide anti-cancer agent.
    Chen SF; Behrens DL; Behrens CH; Czerniak PM; Dexter DL; Dusak BL; Fredericks JR; Gale KC; Gross JL; Jiang JB
    Anticancer Drugs; 1993 Aug; 4(4):447-57. PubMed ID: 8400347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study.
    van den Broek LA; Lázaro E; Zylicz Z; Fennis PJ; Missler FA; Lelieveld P; Garzotto M; Wagener DJ; Ballesta JP; Ottenheijm HC
    J Med Chem; 1989 Aug; 32(8):2002-15. PubMed ID: 2754719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological characterization of a novel antitumor quinolone.
    Clement JJ; Burres N; Jarvis K; Chu DT; Swiniarski J; Alder J
    Cancer Res; 1995 Feb; 55(4):830-5. PubMed ID: 7850797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models.
    Hendriks HR; Pizao PE; Berger DP; Kooistra KL; Bibby MC; Boven E; Dreef-van der Meulen HC; Henrar RE; Fiebig HH; Double JA
    Eur J Cancer; 1993; 29A(6):897-906. PubMed ID: 8484984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease.
    Gundersen S; Aamdal S; Fodstad O
    Br J Cancer; 1987 Apr; 55(4):433-5. PubMed ID: 3580266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.
    Dive C; Workman P; Watson JV
    Cancer Chemother Pharmacol; 1989; 25(3):149-55. PubMed ID: 2557170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude mice.
    Howell SB; Jenkins RS; Streifel J
    Cancer Res; 1979 Oct; 39(10):3875-80. PubMed ID: 476623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of drug sensitivity on human colon adenocarcinoma cells grown in soft agar and in athymic mice.
    Zirvi KA; Masui H; Giuliani FC; Kaplan NO
    Int J Cancer; 1983 Jul; 32(1):45-51. PubMed ID: 6862693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
    Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
    Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 404.